+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Asthma Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Asthma Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Human Papillomavirus (HPV) Vaccine Global Market Report 2024 - Product Thumbnail Image

Human Papillomavirus (HPV) Vaccine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Equine encephalitis - Pipeline Insight, 2024 - Product Thumbnail Image

Equine encephalitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Global Hepatitis B Virus (HBV) Vaccine Market (by End User, Composition, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027) - Product Thumbnail Image

Global Hepatitis B Virus (HBV) Vaccine Market (by End User, Composition, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)

  • Report
  • November 2023
  • 124 Pages
  • Global
From
United States Skin Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028 - Product Thumbnail Image

United States Skin Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • October 2023
  • 90 Pages
  • United States
From
Asia Pacific Biosimilar Insulin Glargine & Lispro Market, Competition, Forecast & Opportunities, 2018-2028 - Product Thumbnail Image

Asia Pacific Biosimilar Insulin Glargine & Lispro Market, Competition, Forecast & Opportunities, 2018-2028

  • Report
  • October 2023
  • 138 Pages
  • Asia Pacific
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 181 Pages
  • Global
From
Hormone Replacement Therapy Market Size, Share & Trend Analysis By Product (Estrogen & Progesterone Replacement Therapy), By Route of Administration, By Disease Type, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Hormone Replacement Therapy Market Size, Share & Trend Analysis By Product (Estrogen & Progesterone Replacement Therapy), By Route of Administration, By Disease Type, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • May 2023
  • 123 Pages
  • Global
From
Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029 - Product Thumbnail Image

Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029

  • Drug Pipelines
  • December 2022
  • 148 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 307 Pages
  • Global
From
Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 359 Pages
  • Global
From
Skin Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Skin Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Unresectable Hepatocellular Carcinoma Market by Systemic Treatment, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Unresectable Hepatocellular Carcinoma Market by Systemic Treatment, End User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 198 Pages
  • Global
From
Liver Cancer Drugs Market by Type, Distribution channel - Global Forecast 2025-2030 - Product Thumbnail Image

Liver Cancer Drugs Market by Type, Distribution channel - Global Forecast 2025-2030

  • Report
  • October 2024
  • 192 Pages
  • Global
From
Respiratory Inhaler Devices Global Market Report 2024 - Product Thumbnail Image

Respiratory Inhaler Devices Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Community-acquired pneumonia (CAP) - Pipeline Insight, 2024 - Product Thumbnail Image

Community-acquired pneumonia (CAP) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Equine Pharmaceuticals and Supplements Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028 - Product Thumbnail Image

Equine Pharmaceuticals and Supplements Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

  • Report
  • November 2022
  • 100 Pages
  • Global
From
HIV Drugs Market - Product Thumbnail Image

HIV Drugs Market

  • Report
  • June 2023
  • 158 Pages
  • Global
From
Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Gender (Male, Female), By Treatment (Pharmaceuticals, Devices), By End-use (Dermatology Clinics, Homecare Settings), By Sales Channel, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Gender (Male, Female), By Treatment (Pharmaceuticals, Devices), By End-use (Dermatology Clinics, Homecare Settings), By Sales Channel, And Segment Forecasts, 2024 - 2030

  • Report
  • February 2024
  • 150 Pages
  • Global
From
Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World - Product Thumbnail Image

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

  • Report
  • November 2023
  • 63 Pages
  • Global
Loading Indicator